Ch. 6: Handling Hazardous Drugs Flashcards
Hazardous drugs that require special handling to avoid toxicity to workers (Preg. X drugs, antineoplastics, 5-alpha reductase inh., hormones, transplant drugs, others)
All Pregnancy X drugs, many Category D’s and a few C’s, and paroxetine, MTX, misoprostol, mifeprostone (Mifeprex), ribavirin, valproic acid
Antineoplastics (daunorubicin)
5-alpha reductase inhibitors (dutasteride, finasteride)
Hormones (contraceptives, estradiol, testosterone)
Transplant drugs (myophenolate, tacrolimus, cyclosporine, everolimus, sirolimus)
Others: colchicine, dronedarone, fluconazole, spironolactone, risperidone, raloxifene, rasagiline, ziprasidone, ganciclovir
When USP 800 will become federally forceable
July 2018
Engineering Controls
Primary Engineering Control (CPEC) -Ventilated “hood”
Secondary Engineering Control (C-SEC)- the room where the hood is located
NIOSH
Determines which drugs are hazardous
USP 800
Sets standards on how to work safely with HDs
ASHP
Provides detailed guidance for hospital pharmacists on implementing the USP standards
Exception to HD separate room standard
Sterile and NS-HD drugs can be prepared n the same room if the room maintains ISO 7 air during NS compounding, Must be at least 1 meter apart. Particle generating activity, such as working with powders, cannot be performed when sterile compounding is being performed.
PPE required in HD compounding
Head covers, hair covers, two pairs of shoe covers, gowns, and two pairs of chemotherapy gloves
Acceptable C-PECs specific to Sterile HD compounding
Class II Biological Safety Cabinet (Class II BSC) or Compounding Aseptic Containment Isolator (CACI)
C-PEC air type vs. anteroom and buffer room
C-PEC has ISO-5 air at 12 ACPH
Anteroom and Buffer room have ISO-7 air at 30 ACPH
Closed System Transfer Devices (CSTDs)
Keep HDs contained within (inside) the device and block entry of environmental contaminants.
Recommended when compounding HDs and REQUIRED when administering antineoplastics
Staff training for handling HDs must be completed and repeated:
Annually
Repeated when a new HD, a new piece of equipment, or some type of process that involves HDs is implemented
Antineoplastics that require manipulation and all HD active pharmaceutical ingredients (i.e. progesterone) must be stored:
Stored separately from other non-HDs in an externally ventilated, negative-pressure room with at least 12 or more ACPH in order to prevent contamination and personnel exposure
Refrigerated antineoplastics must be stored:
Stored in a dedicated refrigerator (for antineoplastics) in a negative pressure area with at least 12 ACPH (such as the buffer room)
Administration of HDs must be done with:
Two pairs of chemotherapy gloves
Gowns are required when administering injectable antineoplastics and recommended when administering other HDs that are not in tablet of capsule form.
Single chemotherapy gloves are acceptable when administering intact tablets of capsules